97401659
May 9, 2022
Pharmaceuticals for treatment of ophthalmic diseases and conditions; Ophthalmic preparations; Pharmaceutical preparations for the treatment of eye diseases and conditions; Medical inserts namely, implantable intravitreal drug delivery devices sold filled with ophthalmic pharmaceutical preparations for treating glaucoma, dry eye disease, macular degeneration, and lowering intraocular pressure; Pharmaceutical preparations for the treatment of glaucoma, dry eye disease, and macular degeneration; Pharmaceutical preparations for the treatment of lowering intraocular pressure; Medical insert, namely, implantable intravitreal drug delivery devices sold filled with pharmaceutical preparations in the nature of dexamethasone for the treatment of eye diseases and conditions; Medical insert, namely, implantable intravitreal drug delivery devices sold filled with pharmaceutical preparations in the nature of dexamethasone for post-op pain and inflammation of the eye, and itching associated with allergic conjunctivitis
PharmaceuticalsResearch and development in the pharmaceutical and biopharmaceutical fields; Development of pharmaceutical and biopharmaceutical preparations, inserts, implants, and medicines; Pharmaceutical and biopharmaceutical products development
Computer and Scientific